	Nationwide trends and outcomes of percutaneous coronary intervention for stable ischemic heart disease in end-stage kidney disease: a longitudinal study. Ann Transl Med Vasudeva R, Mehta H, Chan WC, Jiwani S, Yarlagadda SG, Acharya P, Gunasekaran P, Hajj G, Wiley M, Hockstad E, Tadros P, Gupta K. PMID: 39817250 [PubMed]
	Next step towards point-of-care molecular diagnosis of female genital schistosomiasis (FGS): evaluation of an instrument-free LAMP procedure. Front Parasitol van Bergen KJM, Brienen EAT, Randrianasolo BS, Ramarokoto CE, Leutscher P, Kjetland EF, van Diepen A, Dekker F, Saggiomo V, Velders AH, van Lieshout L. PMID: 39817178 [PubMed]
	Predictors of Mortality among End-Stage Renal Disease Patients with COVID-19 Admitted in a Philippine Tertiary Government Hospital: A Retrospective Cohort Study. Acta Med Philipp Suaybaguio SB, Jamias JD, Briones MVA. PMID: 39817110 [PubMed]
	A new parameter to increase the predictive value of multiparametric prostate magnetic resonance imaging for clinically significant prostate cancer in targeted biopsies: lesion density. Prostate Int , Çelik S, Sözen S, Türkeri L, Aslan G, Yaz, Çetin S, Members of Turkish Urooncology Association. PMID: 39816942 [PubMed]
	Comparison of oncological outcomes between extended and no pelvic lymph node dissection in patients with high- or very high-risk prostate cancer: a multi-institutional study. Prostate Int Washino S, Kawase M, Shimbo M, Yamasaki T, Ohba K, Miki J, Miyagawa T, Koie T. PMID: 39816941 [PubMed]
	The association between inflammatory bowel disease and risk of prostate cancer: a population-based retrospective study based on Korean National Health Insurance Service database. Prostate Int Jung G, Song B, Kim JK, Kim H, Lee J, Hong SK. PMID: 39816938 [PubMed]
	Negative magnetic resonance imaging cannot be used to omit an initial prostate biopsy - An ambispective study. Prostate Int Arulraj K, Sharma S, Das CJ, Seth A, Kumar R. PMID: 39816937 [PubMed]
	Current status and therapeutic value of extended pelvic lymph node dissection during radical prostatectomy for prostate cancer. Prostate Int Morizane S, Takenaka A. PMID: 39816936 [PubMed]
	Insights from immunomics and metabolomics on the associations between prostatic diseases and coronavirus disease 2019. Prostate Int Yang F, Guo P, Wang K, Zhang X, Hu Z, Lou Q, Ge Q, Chen Y, Liang C, Meng J. PMID: 39816935 [PubMed]
	Unveiling urinary extracellular vesicle mRNA signature for early diagnosis and prognosis of bladder cancer. Theranostics Sun N, Zhang Z, Yang X, Li J, Li Q, Kang J, Wei Y, Yu X, Du R, Hong X, Liu G, Gao H, Liu D. PMID: 39816677 [PubMed - indexed for MEDLINE]
	Association of branched-chain amino acids and risk of three urologic cancers: a Mendelian randomization study. Transl Cancer Res Huang H, Qin J, Wen Z, Wang C, Chen C, Liu Y, Li H, Cao S, Yang X. PMID: 39816560 [PubMed]
	Mapping a Decade of Research: Bibliometric Analysis of Iron Overload in Chronic Kidney Disease. Cureus Nashwan AJ, Kunjavara J, Al-Mashdali A, Yassin MA. PMID: 39816307 [PubMed]
	Urogenital Manifestations in Mpox (Monkeypox) Infection: A Comprehensive Review of Epidemiology, Pathogenesis, and Therapeutic Approaches. Infect Drug Resist He S, Zhao J, Chen J, Liang J, Hu X, Zhang X, Zeng H, Sun G. PMID: 39816240 [PubMed]
	SPOP enhances FADD degradation and decreases the activeness of the NF-ÎºB signaling pathway in prostate cancer: an in vitro study. Transl Androl Urol Niu Y, Yang F, Wang C, Shayiti F, Liu X, Bi X, Chen P. PMID: 39816234 [PubMed]
	An 11-gene glycosyltransferases-related model for the prognosis of patients with bladder urothelial carcinoma: development and validation based on TCGA and GEO datasets. Transl Androl Urol Li W, Zuo K, Zhao Q, Guo C, Liu Z, Liu C, Jing S. PMID: 39816229 [PubMed]
	Development of a machine learning-based predictive model for transitional cell carcinoma of the renal pelvis in White Americans: a SEER-based study. Transl Androl Urol Liu Z, Ma H, Guo Z, Su S, He X. PMID: 39816222 [PubMed]
	Construction of a disulfidptosis-associated lncRNA signature to predict prognosis in bladder cancer. Transl Androl Urol Wang J, Zheng Q, Jian J, Chen Z, Liu X, Wan S, Wang L. PMID: 39816221 [PubMed]
	Clinicopathologic features and prognosis of incidental prostate cancer after radical cysto-prostatectomy: a comparative study between China and the West. Transl Androl Urol Ni R, Lai S, Hu H, Seery S, Xu T, Hu H. PMID: 39816220 [PubMed]
	Long non-coding RNAs as prognostic biomarkers in non-muscle invasive bladder cancer: A systematic review. Narra J Hendri AZ, Suryawati S, Heriyanto DS, Hardianti MS, Pikatan NW, Shaleh S, Robert R, Febriyanto T, Liliana B, Angga Dm P. PMID: 39816119 [PubMed - indexed for MEDLINE]
	Effects of decursinol angelate on viability and apoptosis in PC-3 prostate cancer cells: In vitro study. Narra J Rahman ZA, Hidayatullah F, Pratama PK, Andhika DP, Hakim L. PMID: 39816102 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 437237

Page 1 of 21862



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy